Validation of the Essen risk scale and its adaptation to the Spanish population. Modified Essen risk scale;Validación de la escala de riesgo de Essen y su adaptación a la población española. Escala de riesgo de Essen modificada

Neurologia

Volumn 23, Issue 4, 2008, Pages 209-214

  Álvarez Sabín, José ^a   Quintana, M ^a   Rodriguez M ^b   Arboix, A ^c   Ramirez J M ^d   Fuentes, B ^e  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c HOSPITAL UNIVERSITARI SAGRAT COR   (Spain)

^d HOSPITAL SAN PEDRO DE ALCÁNTARA   (Spain)

^e HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Essen risk scale; Stroke; Vascular episodes

Indexed keywords

ADULT; AGED; ALCOHOLISM; ARTICLE; DYSLIPIDEMIA; ESSEN RISK SCALE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; HYPERTENSION; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; RECURRENCE RISK; REGISTER; SENSITIVITY AND SPECIFICITY; SMOKING; SPAIN; STROKE;

AGED; FEMALE; HUMANS; MALE; RECURRENCE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SPAIN; STROKE;

EID: 46049104459     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Álvarez Sabín J, Alonso de Leciñana M, Gallego J, Gil Peralta A, Casado I, Castillo J, et al. Plan de atención sanitaria al ictus. Neurología 2006;21:717-26.
2. Coull AJ, Lovett JK, Rothwell PM, on behalf of the Oxford Vascular Study. Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ 2004;328: 326-8.
3. Lovett JK, Coull AJ, Rothwell PM. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 2004;62:569-74.
4. Clark TG, Murphy MFG, Rothwell PM. Long term risks of stroke, myocardial infarction, and vascular death in «low risk» patients with a non-recent transient ischaemic attack. J Neurol Neurosurg Psychiatry 2003;74:577-80.
5. Hardie K, Hankey GJ, Jamrozik K, Broadhurst RJ, Anderson C. Ten-year survival after first-ever stroke in the perth community stroke study. Stroke 2003;34:1842-6.
6. Kaplan RC, Tirschwell DL, Longstreth WT, Manolio TA, Heckbert SR, Lefkowitz D, et al. Vascular events, mortality, and preventive therapy following ischemic stroke in the elederly. Neurology 2005;65:835-42.
7. Arenillas JF, Molina CA, Montaner J, Abilleira S, González M, Alvarez-Sabín J. Progression and clinical recurrence of symptomatic middle cerebral artery stenosis. A long-term follow-up transcranial Doppler ultrasound study. Stroke 2001;32:2898-904.
8. Ringleb PA, Bhatt DL, Hircsh AT, Topol FJ, Hacke W for the CAPRIE investigators. Benefit of Clopidogrel over Aspirin is amplified in patients with a history of ischemic events. Stroke 2004; 35:528-32.
9. Diener HC, Ringleb PA, Savi P. Clopidogrel for the secondary prevention of stroke. Expert Opin. Pharmacother 2005;6:755-64.
10. Arboix A, Díaz J, Pérez-Sempere A, Álvarez- Sabín J. Ictus: tipos etiológicos y criterios diagnósticos. Neurología 2002;17(Suppl. 3): 3-12.
11. Heald CL, Fowkes FGR, Murray GD, Price JF. Risk of mortality and cardiovascular disease associated with the ankle-brachial index: Systematic review. Atherosclerosis 2006;189:61-9.
12. Agnelli G, Cimminiello C, Meneghetti G, Urbinatis S. Low ankle-brachial index predicts an adverse 1 year outcome after acute coronary and cerebrovascular events. J Thromb Haemost 2006;4:2599-606.
13. Doobay AV, Anand SS. Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review. Arterioscler Thromb Vasc Biol 2005;25:1463-9.